B. Riley began coverage on shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) in a report published on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $23.00 target price on the stock.
Separately, StockNews.com raised Tactile Systems Technology from a buy rating to a strong-buy rating in a report on Friday, September 20th.
Get Our Latest Stock Analysis on TCMD
Tactile Systems Technology Price Performance
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.10. Tactile Systems Technology had a net margin of 11.57% and a return on equity of 16.94%. The firm had revenue of $73.22 million during the quarter, compared to analyst estimates of $72.62 million. On average, sell-side analysts forecast that Tactile Systems Technology will post 0.63 EPS for the current year.
Hedge Funds Weigh In On Tactile Systems Technology
Several large investors have recently added to or reduced their stakes in the company. Quarry LP bought a new stake in shares of Tactile Systems Technology during the 2nd quarter valued at $46,000. Mackenzie Financial Corp bought a new stake in Tactile Systems Technology during the second quarter valued at about $166,000. AQR Capital Management LLC raised its holdings in Tactile Systems Technology by 1.9% during the second quarter. AQR Capital Management LLC now owns 269,431 shares of the company’s stock valued at $3,217,000 after acquiring an additional 4,961 shares during the period. AXA S.A. purchased a new position in shares of Tactile Systems Technology in the second quarter valued at about $446,000. Finally, Paradigm Capital Management Inc. NY boosted its stake in shares of Tactile Systems Technology by 90.1% in the second quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock worth $14,135,000 after acquiring an additional 561,073 shares during the period. Hedge funds and other institutional investors own 83.43% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- Canadian Penny Stocks: Can They Make You Rich?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- What Are Dividend Contenders? Investing in Dividend Contenders
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Why Invest in High-Yield Dividend Stocks?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.